Astragaloside IV attenuates renal tubule injury in DKD rats via suppression of CD36-mediated NLRP3 inflammasome activation

Background:In recent years, diabetic kidney disease (DKD) has emerged as a prominent factor contributing to end-stage renal disease. Tubulointerstitial inflammation and lipid accumulation have been identified as key factors in the development of DKD. Earlier research indicated that Astragaloside IV...

وصف كامل

التفاصيل البيبلوغرافية

الحاوية / القاعدة:	Frontiers in Pharmacology
المؤلفون الرئيسيون:	Xianhong Li, Xin Dong, Liangyou Zhang, Shu Zhang, Weiying Huang, Chao Wang, Zhihao Huo, Xin Li, Xiwen Zhang, Xiaotong Jia, Gangyi Chen, Bin Kuang
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	Frontiers Media S.A. 2024-03-01
الموضوعات:	diabetic kidney disease Astragaloside IV PA-induced HK-2 cells CD36 NLRP3 inflammasome
الوصول للمادة أونلاين:	https://www.frontiersin.org/articles/10.3389/fphar.2024.1285797/full